Dr. Matt Kaeberlein, a Professor at the University of Washington School of Medicine, answers questions from a recent webinar that focused on translational geroscience, the drug rapamycin to target biological aging, and the Dog Aging Project.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
